RankAlpha logo
Back to Rankings

DYAI

Dyadic InternationalF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
DYAI vs peer average
39/100
DYAI vs. peer average (F vs. D)
Grade spread
B 1 · D 4 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

CDXS is the first available peer comparator.

Codexis remains the closest operating-model comparator in this report because its enzymatic and bioprocessing platform model is directionally relevant to Dyadic's attempt to commercialize protein-expression technology through partners. It is not a clean valuation peer because Codexis is larger, more mature, and better capitalized.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCDXSCodexis
DYAI
Dyadic International
CDXS
Codexis
Grade
F
F
Momentum
76
10
Value
41
41
Sentiment
0
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs CDXS

DYAI / CDXS
Grade Position
Below peers
DYAI vs. peer average (F vs. D)
39/100
Momentum
76
DYAI
Value
41
DYAI
Sentiment
0
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs DYAI
1
CDXS
CDXS
F
20/100
Even
2
DNA
DNA
F
20/100
Even
3
CTOR
Citius Oncology Inc Common
F
20/100
Even
4
INMB
INmune Bio Inc Common
F
20/100
Even
5
INKT
MiNK Therapeutics Inc Common
F
20/100
Even
CDXS is the first peer returned for this comparison set.